Journal article
Authors list: Silano, V; Barat Baviera, JM; Bolognesi, C; Brüschweiler, BJ; Cocconcelli, PS; Crebelli, R; Gott, DM; Grob, K; Lampi, E; Mortensen, A; Riviere, G; Steffensen, I‐L; Tlustos, C; Van Loveren, H; Vernis, L; Zorn, H; Glandorf, B; Herman, L; Kärenlampi, S; Penninks, A; Željeżić, D; Aguilera‐Gómez, M; Andryszkiewicz, M; Arcella, D; Kovalkovičová, N; Liu, Y; Roncancio Peña, C; Horn, C; Chesson, A
Publication year: 2018
Pages: 5480-
Journal: EFSA Journal
Volume number: 16
Issue number: 11
DOI Link: https://doi.org/10.2903/j.efsa.2018.5480
Publisher: Wiley
The food enzyme is an endo‐1,4‐β‐xylanase (EC 3.2.1.8) produced with a genetically modified strain of Aspergillus oryzae by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This xylanase is intended to be used in baking and cereal‐based processes. Based on the proposed maximum use levels, dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 0.027 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not raise a safety concern. Subchronic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. In this study, effects were seen in the control group on reproductive parameters (particularly the seminiferous epithelium atrophy in the testes) at incidences that far exceeded the background range. Consequently, a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test, including haematological parameters and the immunology cohort, was conducted. The Panel identified a no observed adverse effect level at the highest dose tested of 1,101.3 mg TOS/kg bw per day. When compared with the dietary exposure, resulted in a sufficiently high margin of exposure (at least 40,000). Similarity of the amino acid sequence to those of known allergens was searched and no match was found. The Panel considered that under the intended conditions of use the risk for allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood is considered low. Based on the data provided, the Panel concluded that this food enzyme does not raise safety concerns under the intended conditions of use.
Abstract:
Citation Styles
Harvard Citation style: Silano, V., Barat Baviera, J., Bolognesi, C., Brüschweiler, B., Cocconcelli, P., Crebelli, R., et al. (2018) Safety evaluation of the food enzyme endo-1,4-β-xylanase from a genetically modified Aspergillus oryzae (strain NZYM-FA), EFSA Journal, 16(11), p. 5480. https://doi.org/10.2903/j.efsa.2018.5480
APA Citation style: Silano, V., Barat Baviera, J., Bolognesi, C., Brüschweiler, B., Cocconcelli, P., Crebelli, R., Gott, D., Grob, K., Lampi, E., Mortensen, A., Riviere, G., Steffensen, I., Tlustos, C., Van Loveren, H., Vernis, L., Zorn, H., Glandorf, B., Herman, L., Kärenlampi, S., ...Chesson, A. (2018). Safety evaluation of the food enzyme endo-1,4-β-xylanase from a genetically modified Aspergillus oryzae (strain NZYM-FA). EFSA Journal. 16(11), 5480. https://doi.org/10.2903/j.efsa.2018.5480